6 Cases Move Forward In Novartis MDL Over Bone Drugs

Law360, New York (December 8, 2010, 6:08 PM EST) -- A federal judge has tossed two suits and nixed strict liability and negligence claims from six other cases in multidistrict litigation accusing Novartis Pharmaceuticals Corp. of failing to warn patients that bone cancer drugs Aredia and Zometa could cause their jawbones to deteriorate.

Judge Todd J. Campbell of the U.S. District Court for the Middle District of Tennessee issued a slew of orders Tuesday on Novartis' motions for summary judgment in eight separate product liability cases consolidated in the MDL for pretrial purposes.

In two cases...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Aredia and Zometa Products Liability Litigation


Case Number

3:06-md-01760

Court

Tennessee Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Todd J. Campbell

Date Filed

April 19, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.